BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Leukemia AND VHL, HRCA1, P40337, 7428, ENSG00000134086, RCA1, VHL1 AND Prognosis
4 results:

  • 1. BRD4 Inhibitor GNE-987 Exerts Anticancer Effects by Targeting Super-Enhancer-Related Gene LYL1 in Acute Myeloid leukemia.
    Sang X; Zhang Y; Fang F; Gao L; Tao Y; Li X; Zhang Z; Wang J; Tian Y; Li Z; Yao D; Wu Y; Chu X; Zhang K; Ma L; Lu L; Chen Y; Yu J; Zhuo R; Wu S; Zhang Z; Pan J; Hu S
    J Immunol Res; 2022; 2022():7912484. PubMed ID: 35958877
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. PBX1, EMCN and ERG are associated with the sub-clusters and the prognosis of vhl mutant clear cell renal cell carcinoma.
    Wang H; Wang X; Xu L; Zhang J
    Sci Rep; 2022 May; 12(1):8955. PubMed ID: 35624190
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Targeted ultra-deep sequencing reveals recurrent and mutually exclusive mutations of cancer genes in blastic plasmacytoid dendritic cell neoplasm.
    Stenzinger A; Endris V; Pfarr N; Andrulis M; Jöhrens K; Klauschen F; Siebolts U; Wolf T; Koch PS; Schulz M; Hartschuh W; Goerdt S; Lennerz JK; Wickenhauser C; Klapper W; Anagnostopoulos I; Weichert W
    Oncotarget; 2014 Aug; 5(15):6404-13. PubMed ID: 25115387
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Cytogenetic characteristics of patients with signs and symptoms of myelodysplastic syndromes in the State of Pará, Brazil.
    Pinto GR; Overal DJ; Moraes LS; Van Den Berg AV; Lemos JA; Smith Mde A; Burbano RR
    Genet Mol Res; 2005 Mar; 4(1):18-30. PubMed ID: 15841432
    [TBL] [Abstract] [Full Text] [Related]  


    of 1.